Randomized clinical trials are the undisputed gold standard for determining whether a treatment protocol is effective for a specific disease or condition.
A Griffith University-led research team has discovered how a therapeutic target common among debilitating neurodegenerative disorders is activated, which could help accelerate drug development.
Endoscopic ultrasound (EUS) plays a vital role in the development of novel treatment and diagnostic methods of gastrointestinal diseases. The ultrasonic transducer is an essential component, […]